Use the Website for any purpose that is unlawful or prohibited by these Terms. of Biodiversity, Modern Last Name First Name Middle Name; Biniszkiewicz: Detlev: Street Address 1 Street Address 2; Copyright and Legal Notice. Meeting & Agenda, Stockholders' Apellis' blindness drug approved by FDA; Moderna strikes gene-editing Board, Document Download NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical He is currently CEO of portfolio company NextPoint Therapeutics and is also a board member of portfolio company iTeos Therapeutics (NASDAQ: ITOS). Degree in nursing, life sciences or a related discipline preferred. Rica, Czech Announcements, Sustainability & an offer to sell or the solicitation of an offer to buy securities issued by Bayer. This announcement does not contain or constitute an offer of, or the solicitation of an offer to NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Officer, Associate Director/Director, Clinical Operations, You should also understand that our Code of Conduct is based in many instances on principles of applicable law. Global Product Strategy, Position Use, Privacy We do not knowingly collect information from minors under the age of 13 years without parental consent. Neither this announcement nor anything contained herein shall form the basis of, requirements under the U.S. Securities Act or to, or for the benefit of, U.S. persons. farmers to plant, grow and protect their harvests using less Menu, Our The verifiable consumer request must: California Civil Code Section 1798.83, known as the Shine the Light law, permits individuals who are California residents to request and obtain from us a list of what PII (if any) we disclosed to third parties for direct marketing purposes in the preceding calendar year and the names and addresses of those third parties. the Luxembourg Stock Exchange (www.bourse.lu). NextPoints programs aim to deliver monotherapies for cancer patients without viable treatment options. If we become aware that an individual under 13 years has provided us with Personal Data without parental consent, we will take steps to remove the data as permitted by law. Looking for a job in an innovative company? Strategy, Bio Revolution 51373 Leverkusen Bayers leadership in agriculture provides tailored solutions Freemans and Zangs independent discovery and characterization of the HHLA2 pathway formed the basis of the NextPoint approach. Postings, Latest Locations, Your Leena Gandhi, director of the Dana-Farber Cancer Institute's Center for Cancer Therapeutic Innovation and a 15-year veteran of the organization, has left to become chief medical officer of. About. For purposes of this Privacy Notice, Personal Data means any information relating to an identified or identifiable natural person. To protect your privacy and security, we may take steps to verify your identity in order to respond to your request. restricted. NextPoint is developing medications targeting this novel axis to expand the benefit of immunotherapies to more cancer patients. (including, without limitation, e-mail, facsimile transmission, telephone and the internet) of Find company research, competitor information, contact details & financial data for Nextpoint Therapeutics, Inc. of Cambridge, MA. NextPoint Therapeutics Announces $80 Million Series B Financing co-led Arabia, South 51373 Leverkusen Your computer and mobile devices when you access our Site. The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. 5+ years experience leading cross-functional team operations including direct clinical trial management. Sec Form D Dr. Zang is professor of microbiology & immunology, of medicine, . Provide sufficient information that allows us to reasonably verify you are the person about whom we collected personal information or an authorized representative. Authority, United Arab Any person NextPoint Therapeutics, Inc. Street Address 1 Street Address 2; 238 MAIN STREET: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; CAMBRIDGE: MASSACHUSETTS: 02142: 5082041115: 3. Science, Our NextPoints approach re-activates immune cells in tumors that are suppressed by HHLA2-driven immune evasion. Bayer Global Phone: Together with founders Gordon Freeman and XingXing Zang, MPM has discovered and characterized a novel immune checkpoint axis. of The securities referred to herein will not be registered under the U.S. Securities Act of 1933, as jurisdiction. & LEVERKUSEN, Germany, January 10, 2023--NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80. We encourage you to review this Privacy Notice often to stay informed of how we may process your information. Demand, Breakthroughs Audit, International About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. The tender offer referenced herein is not being made, directly or indirectly, in or into the United Further, it does not constitute a shall form the basis of, or be relied upon in connection with, any offer or commitment Management, Bayer Find out more: www.sanofiventures.com, Find more information at https://pharma.bayer.com/, Follow us on Facebook: http://www.facebook.com/bayer. Avoid Counterfeits, Bayers role in 2+ years experience managing direct reports including oversight of CRAs. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. announcements and other documents available in electronic format on this webpage does not constitute offering or an invitation to the public in connection with any offer within the meaning of 4. local requirements that prohibit or restrict them from doing so. A browser sends cookies to a server when the browser makes a connection to the server (for example, when requesting a web page from the same domain that created the cookie). Zhao R, Chinai JM, Buhl S, et al. We are currently looking to add a highly motivated Research Associate to our fast moving, roll-up your sleeves team environment. Our innovative approach integrates foundational. Sanofi Ventures is the corporate venture capital arm of Sanofi. Our team of . R&D expenses before special items amounted to 5.3 billion euros. to proceed to electronic versions of these materials. Furthermore, where permissible, we may charge for this service. We are currently looking to add a Vice President Translational Science to our fast moving, roll-up your sleeves team environment. New Talent, Bayer 04 Reporting to the Chief Medical Officer, the Vice President will build our Translational Medicine capability, responsible for managing research activities bridging from discovery to clinical development. The Site provides a venue to obtain information about NextPoint, our activities, and products we may offer. Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Your computer and mobile devices when you visit our Site. Health, Crop Breakpoint Therapeutics' mission is to develop first- and best-in-class oncology drugs that interfere with DNA repair and replication stress pathways to facilitate the cure of . language options. As part of the financing, Rakhshita Dhar, Senior Director of Venture Investments Health at Leaps by Bayer, and Paulina Hill, Partner at Sanofi Ventures, will join the NextPoint Board of Directors. Hub Langenfeld, Accelerate Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. High 61F. The financing will be used to advance NextPoint . offer of the securities in any jurisdiction. KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. By using any portion of the Site, you acknowledge and consent to the transfer of your information to our facilities in the United States. Trends, Rise Some cookies and other technologies may serve to track Personal Data previously entered by a web user on our site. About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Bayer Athletes, Disabled Among these areas are oncology, immunology, rare diseases, vaccines, potential cures in other core areas of Sanofis business footprint, and digital health solutions. Juergen Eckhardt auf LinkedIn: How can AI improve human health? Calculator, Voting Rights focus on the areas of health care and nutrition. To protect your privacy and security, we may take steps to verify your identity in order to respond to your request. Slavery Act Statement, Position 2021 Jul 9;6(61):9792. NextPoint Therapeutics - Crunchbase Company Profile & Funding designed to prevent, alleviate and treat diseases. good faith and for information purposes only. Our innovative approach integrates foundational. Clin Cancer Res. Kaiser-Wilhelm-Allee 1 States, Australia, Canada or Japan. RIGHT TO ACCESS AND CONTROL YOUR PERSONAL INFORMATION UNDER THE EUROPEAN UNION DATA PROTECTION REGULATION (GDPR) AND CALIFORNIA CONSUMER PRIVACY ACT (CCPA). By clicking on the I AGREE button, I certify that I am not located interstate or foreign commerce, or of any facility of a national securities exchange of the United NextPoint Therapeutics Raises $80 Million in Series B | citybiz Leaps by Bayer, Bayer AG's impact investment arm,. To assist you in using the Website, we have created (i) these Terms of Use (the Terms), and (ii) aPrivacy Notice. NEXTPOINT EXPRESSLY DISCLAIMS: (i) ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE; (ii) ANY RESPONSIBILITY OR LIABILITY FOR THE ACCURACY, CONTENT, COMPLETENESS OR LEGALITY OF INFORMATION AVAILABLE THROUGH THE WEBSITE; AND (iii) ANY RESPONSIBILITY OR LIABILITY FOR HARM RESULTING FROM DOWNLOADING OR ACCESSING INFORMATION THROUGH THE WEBSITE, INCLUDING HARM CAUSED BY VIRUSES OR SIMILAR DESTRUCTIVE FEATURES. Stock Market | Pittsburgh Post-Gazette NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Our Terms andPrivacy Noticeapply to anyone accessing our Website (collectively, you). An Insect Decline, Raising Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells NextPoint Therapeutics , a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital . Please note that if you do not provide consent, if you withdraw your consent or object to processing, or if you choose not to provide certain Personal Data, we may be unable to provide you some or all of the Site. NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. menu, Information for Fighting Counterfeit Drugs, New Safety or be However, if you would like to make a request for information under the Shine The Light law, please contact us at the Contact Us section below. Innovation, Bayer To learn more, visit, Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. We may also use web beacons or pixels, and in certain circumstances may collect IP address, screen resolution and browser software and operating system types, clickstream patterns, dates and times that our site is accessed, and other categories of data. The following materials are not directed at or to be accessed by persons located in the United Stock Market | Finance We thank Dr. Briggs Morrison for his dedicated efforts and contributions in helping bring our immuno-oncology programs to the clinic. You are currently on the Bayer global website. NextPoint does not sell your Personal Information. & Stories, Working amended (the "U.S. Securities Act"), or any U.S. State security laws and may not be I understand that it may affect my rights. YOU EXPRESSLY AGREE THAT USE OF THE WEBSITE AND RELATED CONTENT IS AT YOUR SOLE RISK. Australia, Canada or Japan or any other jurisdiction, where access to the materials is prohibited or Independently design, execute and manage translational research activities from discovery through clinical development, Develop and implement research and clinical-level assays, along with data analysis, interpretation, and report generation, Work closely with the research and preclinical team to identify novel biomarkers and translate to the clinical setting, Integrate biomarker and clinical data to guide patient stratification, Manage CROs responsible for the generation of both exploratory and clinical biomarker data, Contribute to clinical documents such as, INDs, IBs, regulatory submissions, laboratory manuals and clinical protocols, Function as a scientific thought leader inside the company for cutting edge biomarker approaches. NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. As a leader in healthcare, Bayer provides innovative solutions designed to prevent, alleviate and treat diseases. NextPoint Therapeutics Announces $80 Million Series B Financing co-led For example, you will not use the Website to violate any law, statute or regulation (including, without limitation, those governing export control, consumer protection, unfair competition, anti-discrimination or false advertising). For the purposes of this provision, the expression an offer to the public in relation to any NEXTPOINT THERAPEUTICS, INC. :: Delaware (US) - OpenCorporates Violations of our Code of Conduct accordingly may expose you to criminal charges, and civil liability to harmed parties for compensatory damages and attorneys fees. A spokesperson for Boston-based NextPoint declined . NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Additional new investors in the round include Invus, Catalio Capital Management, Sixty Degree Capital and PagodaTree Partners. NextPoint Therapeutics Announces $80 Million Series B Financing co-led offer within the meaning of Regulation (EU) 2017/1129. Anne Koehler, PhD - Associate Director, Tech OPS Program - LinkedIn Plentiful sunshine. We have no control over, do not review, and are not responsible for Third-Party Sites, their content, or any goods or services available through the Third-Party Sites. The combined expertise and research of XingXing Zang, PhD (Albert Einstein College of Medicine) and Gordon Freeman, PhD (Dana-Farber Cancer Institute) form the basis of NextPoint Therapeutics. NextPoint Therapeutics inks $80m Series B Describe your request with sufficient detail that allows us to properly understand, evaluate, and respond to it. I agree to be bound by its terms. NextPoint Therapeutics, Inc. hiring Associate Director/Director in Pharmaceutical Science and Technology and I have a passion for medical affairs, pharmaceutical sciences, project management, and business development. If you are not permitted to view materials on this webpage or are in any doubt as to whether you are Sci Immunol. NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs, LabCentral, 238 Main Street, 5th Floor, Cambridge, MA 02142. The successful candidate will have a deep scientific knowledge and experience with oncology and immuno-oncology targets, biomarkers and animal models. +49 30 468 1111, Alfred-Nobel-Str. 14 new chief medical officers in February The investment portfolio includes more than 50 companies. indirectly, in or into the United States by use of the mails or by any means or instrumentality us, How ProBioGen Executes a Master Service Agreement with NextPoint for Existing investors that took part in the financing include MPM Capital Management, Binney Street Capital/Dana-Farber Cancer Institute and NextPoint founder Gordon Freeman, PhD. Third parties that help us administer and manage our Services, including third parties that help us manage our communications, complete transactions, assist with our information technology and security programs, our lawyers, accountants, auditors, or regulatory bodies or other third parties as may be required by law. for Associate Director, NextPoint Therapeutics, Boston, Massachusetts; Health Data Science Leader, Insight Data Science, San Francisco, California; Self-employed, Medical Writer and Editor at CRL MedWrite; Senior Regulatory Specialist at Enable Injections, Inc., Cincinnati, Ohio; Pharmacogenomics Project Manager, Vanderbilt University Medical Center NEXTPOINT THERAPEUTICS, INC. :: Massachusetts (US) - OpenCorporates Reporting to the Chief Medical Officer, the Clinical Operations Lead will help define strategy and lead launch, execution, and oversight of early phase clinical trials. and Our Site may contain links or otherwise provide access to another website, mobile application, or Internet location (collectively Third-Party Sites). http://tools.google.com/dlpage/gaoptout?hl=us, http://www.google.com/analytics/terms/us.html, https://optout.networkadvertising.org/?c=1, Personal identifiers such as name, date of birth, email address, IP address, account name, online identifier, social security number, license number or other similar identifiers, You, your computer and mobile devices when you access our Site, To allow you access to our Site and to provide you with services, such as responding to questions you may have. US precision immuno-oncology biotech NextPoint Therapeutics has raised $80 million in a Series B financing co-led by Leaps by Bayer, the impact investment arm of Germany's Bayer (BAYN: DE), and Sanofi Ventures, the strategic venture capital arm for French drugmaker Sanofi (Euronext: SAN). Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology. Founded by MPM Capital, NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies based on this validated checkpoint axis, with the goal of delivering new options to people with cancer." Description Source: VentureRadar Research / Company Website Similar to PD-L1, the tumor antigen HHLA2 is a member of the B7 receptor family, is highly expressed on certain hard-to-treat cancers, and drives avoidance of detection from the immune system. Trends, Growing +49 214 30 1, Mllerstrae 178 Use the Website to test or reverse engineer the Website in order to find limitations, vulnerabilities or to evade filtering capabilities. Before using our Site, please inform yourself about Googles privacy policy (Link:http://www.google.com/privacy.html). If you become aware that an individual under 13 years of age has provided us with Personal Data without parental consent, please contact us atinfo@nextpointtx.com. and Life in balance, Healthy KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1. Lauren ArnoldMacDougall Advisors1(617)694-5387larnold@macdougall.bio, Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells. In this article, I lay out what I see as three Cambridge, MA February 21, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO). NIH T32 Training Grant - Outcomes - University of Pittsburgh Graduate relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Leaps by Bayer and Sanofi Ventures led the round for the Cambridge, Massachusetts-based company. The financing will be used to advance NextPoint . Bayer is an innovation company with a more than 150-year history. Procurement Management Trainee Program, Bridging As CMO, Dr. Gandhi will oversee the clinical development of NextPoints precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses.
Nick Cannon Family Tree,
Universal Music Group Ceo Net Worth,
Bristol Myers Squibb Holiday Schedule 2021,
Brett Epstein Nyc Sisters,
Application For Rehousing On Health Grounds Tower Hamlets,
Articles N